Orlando Pharmaceutical Private Limited
About Orlando Pharmaceutical Private Limited
Data last updated:
Orlando Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 05 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33309GJ2017PTC097240. Its GSTIN is 24AACCO4959R1ZP (Gujarat).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Uday Ashwinbhai Patel and Harshal Prafulla Desai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/1225B Office – 403 & 404 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.59 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net loss of ₹9,144 (net margin -0.1%) and EBITDA of ₹1.06 Lakh (EBITDA margin 0.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Orlando Pharmaceutical Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address1/1225B Office – 403 & 404 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Orlando Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Orlando Pharmaceutical Private Limited
FY 2025 filings availableOrlando Pharmaceutical Private Limited reported revenue of ₹1.59 Cr (down 56% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 56% in the latest year. EBITDA rose 28% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹1.59 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.06 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹9,144 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.7% | ||
| Net Profit Margin | -0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Orlando Pharmaceutical Private Limited, buy the company report.
Board of directors of Orlando Pharmaceutical Private Limited
Orlando Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Ashwinbhai Patel | Director | 05 May 2017 | 9 Years 6 Months | Current |
| Harshal Prafulla Desai Also directs: Ardor Drugs Private Limited | Director | 05 May 2017 | 9 Years 6 Months | Current |
Auditor
Orlando Pharmaceutical Private Limited is audited by T DHOLAKIYA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T DHOLAKIYA & CO | FY 2020 | 151524W |
Shareholding
The shareholding of Orlando Pharmaceutical Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Orlando Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orlando Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orlando Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orlando Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCO4959R1ZP | Gujarat | Active | 26 Jul 2017 |
To see the full GST registrations and return filing status of Orlando Pharmaceutical Private Limited, buy the company report.
Recent activity
Orlando Pharmaceutical Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Bhagwati Maghan Rattesar ceased to be Director on 23 Jul 2018.
Frequently asked questions
Orlando Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 05 May 2017 (9+ years old) and is registered under CIN U33309GJ2017PTC097240.
Orlando Pharmaceutical has 2 current directors:
- Uday Ashwinbhai Patel - Director
- Harshal Prafulla Desai - Director
The latest financial statements of Orlando Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Orlando Pharmaceutical is 24AACCO4959R1ZP, registered in Gujarat.
The CIN (Corporate Identification Number) of Orlando Pharmaceutical is U33309GJ2017PTC097240. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orlando Pharmaceutical was incorporated on 05 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Bhagwati Maghan Rattesar ceased to be Director on 23 Jul 2018. Kamlesh Hiralal Advani ceased to be Director on 23 Jul 2018. Harshal Prafulla Desai was appointed as Director on 05 May 2017. Orlando Pharmaceutical has 4 board changes on record in total.
The registered office of Orlando Pharmaceutical is at 11225B Office – 403 & 404 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001.
Orlando Pharmaceutical operates in the healthcare industry, in the preventive health services segment.
The compliance status of Orlando Pharmaceutical is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
